EUROPHARMA.DK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
Bankruptcy risk for industry  1.5% 1.1% 1.1% 1.1% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.0% 0.5%  
Credit score (0-100)  0 0 0 0 99  
Credit rating  N/A N/A N/A N/A AAA  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 8,959.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 0.0 29,261  
EBITDA  0.0 0.0 0.0 0.0 13,574  
EBIT  0.0 0.0 0.0 0.0 9,631  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 8,387.4  
Net earnings  0.0 0.0 0.0 0.0 6,540.7  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 8,387  

 
See the entire income statement

Balance sheet (kDKK) 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12

Tangible assets total  0.0 0.0 0.0 0.0 104  
Shareholders equity total  0.0 0.0 0.0 0.0 80,611  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 82,142  
Balance sheet total (assets)  0.0 0.0 0.0 0.0 191,713  

Net Debt  0.0 0.0 0.0 0.0 82,142  
 
See the entire balance sheet

Volume 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.0 29,261  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 40  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 191,713  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 0.0 13,573.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 13,748  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 0.0 1.0  

Profitability 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 0.0% 32.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 0.0% 5.1%  
ROI %  0.0% 0.0% 0.0% 0.0% 5.6%  
ROE %  0.0% 0.0% 0.0% 0.0% 8.1%  

Solidity 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
Equity ratio %  0.0% 0.0% 0.0% 0.0% 42.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% 605.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 101.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 3.4%  

Liquidity 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
Quick Ratio  0.0 0.0 0.0 0.0 0.6  
Current Ratio  0.0 0.0 0.0 0.0 1.8  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 0.0 75,235.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2012
N/A
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 339  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 339  
EBIT / employee  0 0 0 0 241  
Net earnings / employee  0 0 0 0 164